These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 20532710)
1. Formulation of a novel tianeptine sodium orodispersible film. El-Setouhy DA; Abd El-Malak NS AAPS PharmSciTech; 2010 Sep; 11(3):1018-25. PubMed ID: 20532710 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and bioequivalence assessment of two formulations of tianeptine sodium in healthy male volunteers. Zheng R; Kim BH Int J Clin Pharmacol Ther; 2014 Sep; 52(9):817-23. PubMed ID: 25109511 [TBL] [Abstract][Full Text] [Related]
3. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use. Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and metabolic parameters of tianeptine in healthy volunteers and in populations with risk factors. Royer RJ; Albin H; Barrucand D; Salvadori-Failler C; Kamoun A Clin Neuropharmacol; 1988; 11 Suppl 2():S90-6. PubMed ID: 3180120 [TBL] [Abstract][Full Text] [Related]
5. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods. Speer I; Preis M; Breitkreutz J Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans--influence of alcohol co-administration. Salvadori C; Ward C; Defrance R; Hopkins R Fundam Clin Pharmacol; 1990; 4(1):115-25. PubMed ID: 2341111 [TBL] [Abstract][Full Text] [Related]
7. In Vitro-In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets. Lee YJ; Kim JE Molecules; 2022 Apr; 27(9):. PubMed ID: 35566178 [TBL] [Abstract][Full Text] [Related]
8. Micronized Zaleplon Delivery via Orodispersible Film and Orodispersible Tablets. Manda P; Popescu C; Juluri A; Janga K; Kakulamarri PR; Narishetty S; Narasimha Murthy S; Repka MA AAPS PharmSciTech; 2018 Apr; 19(3):1358-1366. PubMed ID: 29352403 [TBL] [Abstract][Full Text] [Related]
9. Physical modification of Thai rice starch and its application as orodispersible film former. Limpongsa E; Jaipakdee N Carbohydr Polym; 2020 Jul; 239():116206. PubMed ID: 32414434 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly. Demotes-Mainard F; Galley P; Manciet G; Vinson G; Salvadori C J Clin Pharmacol; 1991 Feb; 31(2):174-8. PubMed ID: 2010563 [TBL] [Abstract][Full Text] [Related]
11. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics. Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669 [TBL] [Abstract][Full Text] [Related]
12. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation. Al-Oran AYF; Yenilmez E Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551 [TBL] [Abstract][Full Text] [Related]
13. Novel delivery approach for ketotifen fumarate: dissofilms formulation using 3² experimental design: in vitro/in vivo evaluation. Fahmy RH; Badr-Eldin SM Pharm Dev Technol; 2014 Aug; 19(5):521-30. PubMed ID: 23713715 [TBL] [Abstract][Full Text] [Related]
14. Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazam. Bala R; Khanna S; Pawar P J Drug Deliv; 2014; 2014():392783. PubMed ID: 25328709 [TBL] [Abstract][Full Text] [Related]
15. Characterization and optimization of orodispersible mosapride film formulations. ElMeshad AN; El Hagrasy AS AAPS PharmSciTech; 2011 Dec; 12(4):1384-92. PubMed ID: 22009305 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study of tianeptine and its active metabolite MC5 in rats following different routes of administration using a novel liquid chromatography tandem mass spectrometry analytical method. Szafarz M; Wencel A; Pociecha K; Fedak FA; Wlaź P; Wyska E Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):185-196. PubMed ID: 29230490 [TBL] [Abstract][Full Text] [Related]
17. Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance Rosuvastatin calcium bioavailability. Zaki RM; Alfadhel M; DevanathaDesikan Seshadri V; Albagami F; Alrobaian M; Tawati SM; Warsi MH; Almurshedi AS Saudi Pharm J; 2023 Jan; 31(1):135-146. PubMed ID: 36685296 [TBL] [Abstract][Full Text] [Related]
18. Formulation development and evaluation of mouth dissolving film of domperidone. Joshi P; Patel H; Patel V; Panchal R J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S108-9. PubMed ID: 23066181 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of novel antihypertensive orodispersible tablets. Khan HU; Hanif M; Sarfraz RM; Maheen S; Afzal S; Sher M; Afzal K; Mahmood A; Shamim A Pak J Pharm Sci; 2017 Sep; 30(5):1557-1565. PubMed ID: 29084673 [TBL] [Abstract][Full Text] [Related]
20. Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization, pharmacokinetic evaluation and its Sinha S; Sonali ; Garg V; Thapa S; Singh S; Chauhan M; Dutt R; Singh RP Drug Dev Ind Pharm; 2022 Jul; 48(7):279-291. PubMed ID: 35913103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]